» Articles » PMID: 29654306

Proinflammatory Cytokines and Response to Molds in Mononuclear Cells of Patients with Meniere Disease

Abstract

Epidemiological studies have found a higher prevalence of allergic symptoms and positive prick tests in patients with Meniere's disease (MD); however the effect of allergenic extracts in MD has not been established. Thus, this study aims to determine the effect of Aspergillus and Penicillium stimulation in cytokine release and gene expression profile in MD. Patients with MD showed higher basal levels of IL-1β, IL-1RA, IL-6 and TNF-α when compared to healthy controls. We observed that IL-1β levels had a bimodal distribution suggesting two different subgroups of patients, with low and high basal levels of cytokines. Gene expression profile in peripheral blood mononuclear cells (PBMC) showed significant differences in patients with high and low basal levels of IL-1β. We found that both mold extracts triggered a significant release of TNF-α in MD patients, which were not found in controls. Moreover, after mold stimulation, MD patients showed a different gene expression profile in PBMC, according to the basal levels of IL-1β. The results indicate that a subset of MD patients have higher basal levels of proinflammatory cytokines and the exposure to Aspergillus and Penicillium extracts may trigger additional TNF-α release and contribute to exacerbate inflammation.

Citing Articles

A rare haplotype of the GJD3 gene segregating in familial Meniere's disease interferes with connexin assembly.

Escalera-Balsera A, Robles-Bolivar P, Parra-Perez A, Murillo-Cuesta S, Chua H, Rodriguez-de la Rosa L Genome Med. 2025; 17(1):4.

PMID: 39815343 PMC: 11737067. DOI: 10.1186/s13073-024-01425-1.


Is endolymphatic hydrops, as detected in MRI, a truly cochleocentric finding?.

Alvarez De Linera-Alperi M, Dominguez P, Blanco-Pareja M, Menendez Fernandez-Miranda P, Manrique-Huarte R, Liano G Front Neurol. 2024; 15:1477282.

PMID: 39687399 PMC: 11646843. DOI: 10.3389/fneur.2024.1477282.


Comparative Proteomic Analysis of Endolymphatic Sac Luminal Fluid in Patients with Meniere's Disease and Controls.

Zhang Z, Wang Q, Zhou Z, Peng A, Jiang W J Inflamm Res. 2024; 17:10209-10222.

PMID: 39649425 PMC: 11625438. DOI: 10.2147/JIR.S474910.


IL-1β promotes glutamate excitotoxicity: indications for the link between inflammatory and synaptic vesicle cycle in Ménière's disease.

Zhang N, Song Y, Wang H, Li X, Lyu Y, Liu J Cell Death Discov. 2024; 10(1):476.

PMID: 39567494 PMC: 11579495. DOI: 10.1038/s41420-024-02246-2.


Effect of betahistine on pro-inflammatory cytokine expression in autoimmune inner ear disease and Meniere's disease patients.

Yellin I, Pathak S, Vambutas A Laryngoscope Investig Otolaryngol. 2024; 9(6):e70032.

PMID: 39525524 PMC: 11541603. DOI: 10.1002/lio2.70032.


References
1.
Derebery M . Allergic management of Meniere's disease: an outcome study. Otolaryngol Head Neck Surg. 2000; 122(2):174-82. DOI: 10.1016/S0194-5998(00)70235-X. View

2.
Vambutas A, Pathak S . AAO: Autoimmune and Autoinflammatory (Disease) in Otology: What is New in Immune-Mediated Hearing Loss. Laryngoscope Investig Otolaryngol. 2016; 1(5):110-115. PMC: 5113311. DOI: 10.1002/lio2.28. View

3.
Adrion C, Fischer C, Wagner J, Gurkov R, Mansmann U, Strupp M . Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ. 2016; 352:h6816. PMC: 4721211. DOI: 10.1136/bmj.h6816. View

4.
Di Berardino F, Cesarani A . Gluten sensitivity in Meniere's disease. Laryngoscope. 2012; 122(3):700-2. DOI: 10.1002/lary.22492. View

5.
Frejo L, Martin-Sanz E, Teggi R, Trinidad G, Soto-Varela A, Santos-Perez S . Extended phenotype and clinical subgroups in unilateral Meniere disease: A cross-sectional study with cluster analysis. Clin Otolaryngol. 2017; 42(6):1172-1180. DOI: 10.1111/coa.12844. View